Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining -0.18% today. In the last week its performance is -0.01%, and 8.25% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 123.95, so today’s gain of -0.18% is a significant step towards its target price. The GAP today is therefore 0.04%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 23974.36, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 88.00%.

At the current price of 112.78, it has a dividend yield of *TBA, and its target price is 123.95. This is with a profit margin of 19.30%, and total debt/equity of 0.24. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 46.74, as well as a forward P/E of 33.29.

With a current EPS of 2.42, and a forecasted EPS growth for next year at 18.30%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 17.68%.

Performance for the year is 50.52%. Since its IPO date on 3/27/2000, the total performance to date is 43.05%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 257500, while its average volume is 1685.98. Whilst the total gain today was -0.18%, it did have a day high of -3.98%.

Volatility for this week has been at 1.46%, and 1.60% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 80.36%, while the 52-week-high has reached -3.98%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.30%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.40%. With a sales growth of 23.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.24, and has a current ratio of 4.2 and 3.4 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.64, and the P/S is 8.74, along with a P/B of 9.7. Meanwhile it has a p/cash of 22.61.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment